48
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment

, , &
Pages 90-95 | Received 12 Jun 2002, Accepted 19 Feb 2003, Published online: 10 Jul 2009

References

  • Robberecht W. Oxidative stress in amyotrophic lateral sclerosis. J Neurol 2000; 247 (suppl) 1: 1–6.
  • Cookson MR, Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol 1999; 9: 165–86.
  • Swerdlow RH, Parks JK, Cassarino DS et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol 1998; 153: 135–42.
  • Hall ED, Andrus PK, Oostveen JA et al. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postis- chemic or methamphetamine-induced degeneration of nigro- striatal neurons. Brain Res 1996; 742: 80–88.
  • Anderson DW, Neavin T, Smith JA, Schneider JS. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res 2001; 905: 44–53.
  • Cassarino DS, Fall CP, Smith TS, Bennett JP Jr. Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition pro- duced by the Parkinsonian neurotoxin methylpyridinium ion. J. Neurochem 1998; 71: 295–301.
  • Marzo I, Brenner C, Kroemer G. The central role of the mito- chondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein com- plexes. Biomed Pharmacother 1998; 52: 248–251.
  • Grootveld M, Halliwell B. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. Biochem J 1986; 15: 499–504.
  • Halliwell B, Kaur H. Hydroxylation of salicylate and phenylala- nine as assays for hydroxyl radicals: a cautionary note visited for the third time. Free Rad Res 1997; 27: 239–244.
  • Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Nat Acad Sci USA 1975; 72: 3073–3076.
  • Hertz F, Cloaree A. Pharmacology of free radicals: recent views on their relation to inflammatory mechanisms. Life Sci 1984; 34: 713–720.
  • Kuehl FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980; 210: 978–984.
  • Sielik PH, Marnett LJ. Oxidizing radical generation by prosta- glandin H synthase. Methods Enzymol 1984; 105: 412–416.
  • Ferger B, Teismann P, Mierau J. The dopamine agonist prami- pexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo micro- dialysis study. Brain Res 2000; 883: 216–23.
  • Kakimura J, Kitamura Y, Takata K et al. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the anti- Parkinson’s drugs, talipexole and pramipexole. Eur J Pharmacol 2001; 417: 59–67.
  • Le WD, Jankovic J, Xie W, Appel SH. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm 2000; 107: 1165–1173.
  • Abramova NA, Cassarino DS, Khan SM et al. Inhibition by R(z) or S(x) pramipexole of activation by methylpyridinium ion or beta amyloid peptide of death pathways in neural cells. J Neurosci Res 2002; 67: 494–500.
  • Bennett JP, Jr, Carvey PM, Hinds TR et al. Mechanisms of action of pramipexole: putative neuroprotective effects. Rev Contemp Pharmacother 2001; 12: 33–58.
  • Pedersen WA, Fu W, Keller JN et al. Protein modification by lipid peroxidation product 4-Hydroxy-nonel in the spinal cords of amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 819–24.
  • Tohgi H, Abe T, Yamazaki K et al. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1999; 46: 129– 131.
  • Aoyama K, Matsubara K, Fujikawa Y et al. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurode- generative diseases. Ann Neurol 2000; 47: 524–527.
  • Shaw PJ, Eggett CJ. Molecular factors underlying selective vulne- rability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 2000; 247 (suppl) 1: I17–27.
  • Borthwick GM, Johnson MA, Ince PG et al. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 1999; 46: 787–790.
  • Liu D, Wen J, Liu J, Liping L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB 1999; 13: 2318–2328.
  • Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 1999; 160: 28–39.
  • Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropath Exp Neurol 1999; 58: 459–471.
  • Li M, Ona VO, Guegan C et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288: 335–339.
  • Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105–16.
  • Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 1998; 18: 3241–50.
  • Vielhaber S, Kunz D, Winkler K et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 2000; 123: 1339–48.
  • Vielhaber S, Winkler K, Kirches E et al. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 133–9.
  • Wiedemann FR, Winkler K, Kuznetsov AV et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 1998; 156: 65–72.
  • Sasaki S, Iwata M. Dendritic synapses of anterior horn neurons in amyotrophic lateral sclerosis: an ultrastructural study. Acta Neuropathol (Berl) 1996; 91: 278–83.
  • Sasaki S, Komori T, Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 2000; 100: 138–44.
  • Ghiseli A, Laurenti O, DeMattia G et al. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Rad Biol Med 1992; 13: 621–626.
  • Thome J, Zhang J, Davids E et al. Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products. Alcohol Clin Exp Res 1997; 21: 82–85.
  • Kaur H, Edmonds SE, Blake DR, Halliwell G. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann Rheum Dis 1996; 55: 915–920.
  • Kaur H, Whiteman M, Halliwell B. Peroxynitrite–dependent aromatic hydroxylation and nitration of salicylate and phenyla- lanine. Is hydroxyl radical involved?. Free Rad Res 1997; 26: 71–82.
  • Narayan M, Berliner LJ, Merola AJ et al. Biological reactions of peroxynitrite: evidence for an alternative pathway of salicylate hydroxylation. Free Rad Res 1997; 27: 63–72.
  • Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836–844.
  • Beckman JS, Beckman TW, Chen J et al. Apparent free radical production by peroxynitrite: implications for endothelial injury form nitric oxide and superoxide. Proc Nat Acad Sci USA 1990; 170: 1620–1624.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.